Tivic Health Systems (TIVC)
(Delayed Data from NSDQ)
$0.51 USD
-0.15 (-22.68%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $0.51 0.00 (-0.31%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Tivic Health Systems, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1 | 2 | 1 | 1 | 0 |
Cost Of Goods | 1 | 2 | 1 | 1 | 1 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 9 | 10 | 6 | 3 | 3 |
Income After Depreciation & Amortization | -8 | -10 | -6 | -3 | -4 |
Non-Operating Income | 0 | 0 | -1 | 0 | 0 |
Interest Expense | 0 | 0 | 2 | 0 | 0 |
Pretax Income | -8 | -10 | -8 | -4 | -4 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -8 | -10 | -8 | -4 | -4 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -8 | -10 | -8 | -4 | -4 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -8 | -10 | -4 | -3 | -4 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 2 | 0 | 0 |
Income After Depreciation & Amortization | -8 | -10 | -6 | -3 | -4 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 0.79 | 0.10 | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | -10.40 | -104.00 | NA | NA | NA |
Diluted Net EPS (GAAP) | -10.40 | -104.00 | -243.00 | -158.00 | NA |
Fiscal Year end for Tivic Health Systems, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 0.33 | 0.36 | 0.28 | 0.16 |
Cost Of Goods | NA | 0.17 | 0.35 | 0.17 | 0.10 |
Gross Profit | NA | 0.17 | 0.00 | 0.11 | 0.06 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 1.65 | 2.25 | 1.87 | 2.19 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -1.48 | -2.25 | -1.76 | -2.13 |
Non-Operating Income | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -1.48 | -2.24 | -1.76 | -2.13 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -1.48 | -2.24 | -1.76 | -2.13 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -1.48 | -2.24 | -1.76 | -2.13 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 1.47 | NA | 1.19 | 0.30 |
Diluted EPS Before Non-Recurring Items | NA | -1.01 | NA | -1.48 | -7.00 |
Diluted Net EPS (GAAP) | NA | -1.01 | 9.08 | -1.48 | -7.00 |